Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Operating income as a percentage of revenue
Latest
-149.62%
↑ 91% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-1586.11%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -149.62% | +33.8% |
| 2024 | -226.11% | +18.2% |
| 2023 | -276.50% | -80.5% |
| 2022 | -153.17% | +87.9% |
| 2021 | -1263.12% | +63.1% |
| 2020 | -3421.35% | -30.1% |
| 2019 | -2630.31% | +10.9% |
| 2018 | -2951.62% | -36.0% |
| 2017 | -2170.87% | +17.1% |
| 2016 | -2618.43% | - |